Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/
You can print this page and show it to your doctor.

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

ProPublica's Dollars for Docs database lets you search for payments to U.S.-based doctors made by pharmaceutical and medical device companies between August 2013 and December 2018. The disclosure of these payments is required under the Physician Payments Sunshine Act, a provision of the 2010 Affordable Care Act.

About This Information

  • The information that appears here comes directly from the federal government. Companies must attest to its accuracy, and doctors have the ability to contest information they believe is in error.
  • This site includes payments for such activities as speaking, consulting, meals, travel and royalties. It does not include payments for clinical research.
  • It is legal for companies to make payments to doctors as long as the payments are not a kickback or inducement to use their products.
  • Some doctors say collaborative relationships, particularly those involving research, are necessary to develop new treatments and cures. But many ethicists have raised questions about the payments, and studies show that they may influence doctors' prescribing decisions.
  • Only you can decide if this matters to you and if so, whether you want to talk with your doctor about it. If you plan to talk with your doctor (or if you already have), please help us by filling out this short survey: propub.li/participate-d4d

Preparing for Your Conversation

If you decide you'd like to talk to your doctor about this, please keep in mind:

  • Many health care professionals in our database have similar names, so you should start by asking your doctor if the person mentioned in this payment record is really him/her.
  • Your doctor may not know he or she is listed as receiving payments, especially if the payments are small. You can direct your doctor to this site (the URL will be printed at the top of the payment record) or directly to the government's site here: https://openpaymentsdata.cms.gov/physician/837803
  • Some doctors are happy to discuss this information with you. Others might not be. The best approach is to ask questions and to not be accusatory.

Questions You Might Want to Ask

  • Is this you?
  • What type of work do you do with these companies?
  • Have you prescribed me any drugs that are manufactured by companies you've taken payments from?
  • Are there non-drug alternatives that I may want to consider first?
  • Are there less expensive generic alternatives to the drugs you have prescribed?
  • What devices have you used in my care that are manufactured by companies you've taken payments from?

Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/doctors/pid/837803
If you spot an error, please let us know at [email protected].

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

MICHAEL DRUMMOND

Listed Specialty: Internal Medicine
4940 EASTERN AVE, BALTIMORE, MD, 21224-2735

2018 Payments: At a Glance

46

payments

$41,636

payment total

5

companies paid this doctor

Types of Payments

Category Payments Payment Value
Consulting
 7 $35,745
Travel and Lodging
 12 $4,503
Food and Beverage
 27 $1,388

Drugs & Devices in 2018

Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.

Product Name Product Type Payments†
STIOLTO RESPIMAT

drug

 $11,620
Payments with no listed product

N/A

 $9,747
NUCALA

drug

 $7,369
FASENRA

drug

 $7,361
YUPELRI

drug

 $4,586
SPIRIVA

drug

 $953
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products.

Payment Details

When How Much Related To What For From Third Party Payee
Oct 25, 2018 $11,445 STIOLTO RESPIMAT Consulting BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
Mar 22, 2018 $7,150 No Listed Product Consulting GLAXOSMITHKLINE, LLC.
Jun 29, 2018 $6,500 NUCALA Consulting GLAXOSMITHKLINE, LLC.
Jun 4, 2018 $5,850 FASENRA Consulting ASTRAZENECA PHARMACEUTICALS LP
Dec 28, 2018 $3,250 YUPELRI Consulting MYLAN SPECIALTY L.P.
Mar 14, 2018 $900 No Listed Product Consulting ASTRAZENECA UK LIMITED
Dec 1, 2018 $805 YUPELRI Travel and Lodging MYLAN SPECIALTY L.P.
Nov 21, 2018 $650 No Listed Product Consulting GLAXOSMITHKLINE, LLC.
Oct 4, 2018 $628 SPIRIVA Travel and Lodging BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
Mar 8, 2018 $468 No Listed Product Travel and Lodging GLAXOSMITHKLINE, LLC.
Apr 18, 2018 $435 FASENRA Travel and Lodging ASTRAZENECA PHARMACEUTICALS LP
May 30, 2018 $432 NUCALA Travel and Lodging GLAXOSMITHKLINE, LLC.
Apr 18, 2018 $404 FASENRA Travel and Lodging ASTRAZENECA PHARMACEUTICALS LP
Apr 18, 2018 $317 FASENRA Travel and Lodging ASTRAZENECA PHARMACEUTICALS LP
Mar 8, 2018 $277 No Listed Product Travel and Lodging GLAXOSMITHKLINE, LLC.
Jun 15, 2018 $225 NUCALA Travel and Lodging GLAXOSMITHKLINE, LLC.
Dec 1, 2018 $186 YUPELRI Travel and Lodging MYLAN SPECIALTY L.P.
Dec 1, 2018 $186 YUPELRI Travel and Lodging MYLAN SPECIALTY L.P.
Jun 15, 2018 $158 NUCALA Food and Beverage GLAXOSMITHKLINE, LLC.
Oct 4, 2018 $145 SPIRIVA Food and Beverage BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.

For ease of printing, 20 payments are displayed, the largest appearing on top. For a full list of payments, please visit: https://projects.propublica.org/docdollars/doctors/pid/837803

Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].

This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.